Modulation of nitric oxide homeostasis in a mouse model of spinal cord injury

Tiziana Genovese1, Emanuela Mazzon, Sofia Mariotto

  • 1Institute of Pharmacology, University of Messina, Italy.

Abstract

Insights

Inhibition of inducible nitric oxide synthase (iNOS) reduces secondary damage after spinal cord injury (SCI). This finding suggests iNOS plays a key role in SCI pathogenesis and offers a potential therapeutic target.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Traumatic spinal cord injury (SCI) causes primary damage followed by secondary damage, including progressive cell death.
  • Inducible nitric oxide synthase (iNOS) is implicated in the inflammatory cascade following SCI.

Purpose of the Study:

  • To investigate the role of iNOS in an experimental mouse model of SCI.
  • To determine if inhibiting iNOS can mitigate secondary damage after SCI.

Main Methods:

  • Wild-type (iNOS+/+) mice were subjected to SCI.
  • Inflammatory markers such as nitrotyrosine formation, PARP activation, and neutrophil infiltration were assessed.
  • Histopathological changes in spinal cord tissue were evaluated.

Main Results:

  • SCI in wild-type mice rapidly induced an inflammatory response, indicating iNOS involvement.
  • Genetic inhibition of iNOS significantly reduced secondary damage post-SCI.
  • Inhibition of iNOS prevented the SCI-induced decrease in neuronal and endothelial NOS activity.

Conclusions:

  • iNOS plays a critical role in the secondary damage cascade following SCI.
  • Genetic inhibition of iNOS demonstrates therapeutic potential for reducing SCI-induced tissue damage.
  • Targeting iNOS may offer a novel strategy for managing spinal cord injuries.